New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
11:18 EDTNUAN, SRPT, IGT, YPF, SBGI, TLM, WMB, APC, MDTOptions with increasing implied volatility
Options with increasing implied volatility: NUAN SRPT IGT YPF SBGI TLM WMB APC MDT
News For NUAN;SRPT;IGT;YPF;SBGI;TLM;WMB;APC;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 15, 2014
11:58 EDTWMBStocks with call strike movement; WMB RIG
Williams (WMB) January 55 call option implied volatility increased 8% to 55, Transocean (RIG) January 5 call option implied volatility increased 5% to 48 according to IVolatility.
10:49 EDTSRPTEbola linked names rise again amid broader market sell-off
Subscribe for More Information
10:48 EDTMDTShire tanks with AbbVie calling board meeting over merger
Subscribe for More Information
October 14, 2014
14:03 EDTMDTMedtronic announces FDA approval of pacing lead for full-body MRI scans
Subscribe for More Information
11:52 EDTAPCStocks with call strike movement; APC GILD
Subscribe for More Information
09:04 EDTSRPTChinese company says drug can cure Ebola, Reuters reports
Subscribe for More Information
08:19 EDTMDTMedtronic begins pivotal study of Predictive Low Glucose Management technology
Subscribe for More Information
08:17 EDTMDTCapricor Therapeutics to acquire certain patent rights from Medtronic
Capricor Therapeutics (CAPR) announced that it has entered into an agreement to acquire patent rights from Medtronic (MDT) relating to the formulation and pump delivery of natriuretic peptides. Capricor recently announced that it plans to develop a clinical program using Cenderitide, a natriuretic peptide, for the treatment of post-acute heart failure.
October 13, 2014
12:44 EDTSRPTSarepta data supported by DMD study in journal, TheStreet reports
A study published in medical journal PLOS One following the progression of Duchenne muscular dystrophy supports Sarepta's push for accelerated approval of eteplirsen, TheStreet's Adam Feuerstein reports. Reference Link
11:23 EDTAPCStocks with call strike movement; APC TSO
Subscribe for More Information
09:22 EDTMDTMedtronic announces positive data from CoreValve ADVANCE DA Study
Subscribe for More Information
07:13 EDTMDTBioFlorida to hold a conference
Subscribe for More Information
October 12, 2014
19:26 EDTSRPTPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTSRPTCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
14:18 EDTSRPTNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTSRPTTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
October 10, 2014
10:54 EDTSRPTMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
08:48 EDTSBGISinclair Broadcast has positive catalysts, fears overdone, says RBC Capital
Subscribe for More Information
08:31 EDTWMBGoldman remains bullish on MLPs
Subscribe for More Information
07:04 EDTMDTMedtronic announces Omar Ishrak will remain CEO of new company
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use